Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Klein (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), L. Frøssing (Copenhagen, Denmark), A. Silberbrandt (Copenhagen, Denmark), U. Bødtger (Næstved, Denmark), K. Romberg (Höllviken, Sweden), L. Bjermer (Lund, Sweden), J. Erjefält (Lund, Sweden), K. Kristiansen (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark). Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study. 3322

Member's Comments

No comment yet.

Related content which might interest you: Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study) Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Real-life COPD patients compared to large trial populations: An UNLOCK external validity study Source: Annual Congress 2013 –Management of respiratory diseases in primary care Year: 2013 Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 A global survey conducted to determine frequency of exacerbations in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Detecting specific clusters of asthma and COPD patients using fluctuation based clustering of daily lung function recordings in the BIOAIR study Source: International Congress 2015 – Any news from the asthma field? Year: 2015 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Sputum characteristics of stable COPD patients after a first admission for an exacerbation. The "phenotype and course of COPD" (PAC-COPD) study Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2017 – Primary care management of asthma and COPD Year: 2017 Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015